What does APOTHEEK NIEUWMOER do?

APOTHEEK NIEUWMOER is a pharmacy in Kalmthout. Private Limited, started on 25 May 2000, 1 establishment.

What is the address of APOTHEEK NIEUWMOER?

The registered office of APOTHEEK NIEUWMOER is located at Nieuwmoer-Dorp (Nm) 11 box A, 2920 Kalmthout.

Is APOTHEEK NIEUWMOER still active?

Yes. According to the CBE (29 October 2026) APOTHEEK NIEUWMOER is active, legal situation “Normale toestand”, started on 25 May 2000.

Is APOTHEEK NIEUWMOER registered on Peppol?

Yes, APOTHEEK NIEUWMOER is registered on the Peppol network with ID 0208:0471967851.

What is the enterprise number of APOTHEEK NIEUWMOER?

The enterprise number of APOTHEEK NIEUWMOER is BE0471967851.

When was APOTHEEK NIEUWMOER founded?

APOTHEEK NIEUWMOER was founded on 25 May 2000.

Who are the directors of APOTHEEK NIEUWMOER?

According to the 2025 annual accounts, the directors of APOTHEEK NIEUWMOER are: Cindy De Roeve.

Is APOTHEEK NIEUWMOER a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 25 May 2000; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK NIEUWMOER make in 2025?

APOTHEEK NIEUWMOER recorded a loss after taxes of € 10,426 in financial year 2025.

What is the revenue of APOTHEEK NIEUWMOER?

As a small company, APOTHEEK NIEUWMOER is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 186,280.

How much does an employee at APOTHEEK NIEUWMOER earn?

The average wage cost per full-time employee at APOTHEEK NIEUWMOER was € 59,300 in 2025: staff costs of € 160,137 for 2.7 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK NIEUWMOER have?

According to the 2025 annual accounts, APOTHEEK NIEUWMOER has 2.7 full-time equivalents (FTE).

APOTHEEK NIEUWMOER (Private Limited) - Kalmthout

Dossier APOTHEEK NIEUWMOER, printed on 29 October 2026 from databakkes.be/en/0471967851/apotheek-nieuwmoer. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 63 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

APOTHEEK NIEUWMOER from Kalmthout, company number BE0471967851, closed financial year 2025 with a result of € -10,426 after tax. For that financial year APOTHEEK NIEUWMOER recorded a gross margin of € 186,280 and equity of € 131,803. Compared with financial year 2024, the result moved from € -15,946 to € -10,426. The company made a loss. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 14, 2026.

What it is worth Healthy

€ 131,803

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -10,426

▲ 35 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 47,843

▲ 34% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € 113,212.

People and assets in 2025

Full-time equivalents

2.7

▲ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 160,137

▲ 9% vs 2024

€ 59,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 9,030

▼ 35% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 3 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 64,356

▼ 23% vs 2024

€ 19,779 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.

Owed to suppliers

€ 106,633

▲ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 18,224

▲ 5% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 134,525 Gross margin 2022: € 134,525 First fiscal year in the series	€ 161,746 Gross margin 2023: € 161,746 ▲ 20% vs 2022 (€ 134,525) Favourable step	€ 178,762 Gross margin 2024: € 178,762 ▲ 11% vs 2023 (€ 161,746) Favourable step	€ 186,280 Gross margin 2025: € 186,280 ▲ 4% vs 2024 (€ 178,762) Favourable step	▲ 4%
Profit after taxes	€ 10,985 Profit after taxes 2022: € 10,985 First fiscal year in the series	€ -2,630 Profit after taxes 2023: € -2,630 ▼ € 13,615 vs 2022 (€ 10,985) Unfavourable step	€ -15,946 Profit after taxes 2024: € -15,946 ▼ € 13,316 vs 2023 (€ -2,630) Unfavourable step	€ -10,426 Profit after taxes 2025: € -10,426 ▲ € 5,520 vs 2024 (€ -15,946) Favourable step	▲ € 5,520
Equity	€ 160,805 Equity 2022: € 160,805 First fiscal year in the series	€ 158,175 Equity 2023: € 158,175 ▼ 2% vs 2022 (€ 160,805) Unfavourable step	€ 142,229 Equity 2024: € 142,229 ▼ 10% vs 2023 (€ 158,175) Unfavourable step	€ 131,803 Equity 2025: € 131,803 ▼ 7% vs 2024 (€ 142,229) Unfavourable step	▼ 7%
Total debts	€ 392,205 Total debts 2022: € 392,205 First fiscal year in the series	€ 346,278 Total debts 2023: € 346,278 ▼ 12% vs 2022 (€ 392,205) Favourable step	€ 350,428 Total debts 2024: € 350,428 ▲ 1% vs 2023 (€ 346,278) Unfavourable step	€ 338,629 Total debts 2025: € 338,629 ▼ 3% vs 2024 (€ 350,428) Favourable step	▼ 3%
Cash	€ 88,102 Cash 2022: € 88,102 First fiscal year in the series	€ 55,211 Cash 2023: € 55,211 ▼ 37% vs 2022 (€ 88,102) Unfavourable step	€ 35,833 Cash 2024: € 35,833 ▼ 35% vs 2023 (€ 55,211) Unfavourable step	€ 47,843 Cash 2025: € 47,843 ▲ 34% vs 2024 (€ 35,833) Favourable step	▲ 34%
Land & buildings	€ 61,473 Land & buildings 2022: € 61,473 First fiscal year in the series	€ 54,643 Land & buildings 2023: € 54,643 ▼ 11% vs 2022 (€ 61,473) Unchanged	€ 47,812 Land & buildings 2024: € 47,812 ▼ 13% vs 2023 (€ 54,643) Unchanged	€ 40,982 Land & buildings 2025: € 40,982 ▼ 14% vs 2024 (€ 47,812) Unchanged	▼ 14%
Retained profit	€ 142,213 Retained profit 2022: € 142,213 First fiscal year in the series	€ 139,583 Retained profit 2023: € 139,583 ▼ 2% vs 2022 (€ 142,213) Unfavourable step	€ 123,637 Retained profit 2024: € 123,637 ▼ 11% vs 2023 (€ 139,583) Unfavourable step	€ 113,212 Retained profit 2025: € 113,212 ▼ 8% vs 2024 (€ 123,637) Unfavourable step	▼ 8%
Dividend	€ 19,254 Dividend 2022: € 19,254 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 19,254) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 127,993 Bank debt 2022: € 127,993 First fiscal year in the series	€ 102,796 Bank debt 2023: € 102,796 ▼ 20% vs 2022 (€ 127,993) Favourable step	€ 83,760 Bank debt 2024: € 83,760 ▼ 19% vs 2023 (€ 102,796) Favourable step	€ 64,356 Bank debt 2025: € 64,356 ▼ 23% vs 2024 (€ 83,760) Favourable step	▼ 23%
Balance sheet total	€ 553,010 Balance sheet total 2022: € 553,010 First fiscal year in the series	€ 504,452 Balance sheet total 2023: € 504,452 ▼ 9% vs 2022 (€ 553,010) Unchanged	€ 492,657 Balance sheet total 2024: € 492,657 ▼ 2% vs 2023 (€ 504,452) Unchanged	€ 470,432 Balance sheet total 2025: € 470,432 ▼ 5% vs 2024 (€ 492,657) Unchanged	▼ 5%
Employees (FTE)	1.5 Employees (FTE) 2022: 1.5 First fiscal year in the series	2.3 Employees (FTE) 2023: 2.3 ▲ 0.8 vs 2022 (1.5) Unchanged	2.6 Employees (FTE) 2024: 2.6 ▲ 0.3 vs 2023 (2.3) Unchanged	2.7 Employees (FTE) 2025: 2.7 ▲ 0.1 vs 2024 (2.6) Unchanged	▲ 0.1

Key figures of APOTHEEK NIEUWMOER, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK NIEUWMOER?

What happened at APOTHEEK NIEUWMOER in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 14, 2026 New annual accounts for financial year 2025: loss of € 10,426. filed late Source: NBB ↗
2012 Cindy De Roeve became a director. NBB
Jun 20, 2000 New establishment in Kalmthout. KBO
May 25, 2000 Start of the company according to the CBE. KBO

In short

From € 10,985 profit in 2022 to € 10,426 loss in 2025.

Paid € 3,144 in corporate taxes since 2022.

Best year ever: 2022, with € 10,985 profit.

On average € 69,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Ibex Care 99.9%

The stake of Ibex Care comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK NIEUWMOER

Behind APOTHEEK NIEUWMOER is Cindy De Roeve. The shares are held by Ibex Care (99.9%).

Directors

According to the 2025 annual accounts

Cindy De Roeve

Director

Also active at: Koninklijke Apothekersvereniging van Antwerpen, Autonoom gemeentebedrijf Kalmthout, Eerstelijnszone Noorderkempen, Ibex Care

since 2012

Shareholders

Ibex Care

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Nieuwmoer-Dorp (Nm) 11 box A

2920 Kalmthout

2.115.824.178

Nieuwmoer-Dorp (Nm) 11A

2920 Kalmthout

Active since 20 June 2000

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

TIRIONS-DELCROIX

€ 28,831 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0471.967.851

VAT number

BE 0471.967.851

Registered office

Nieuwmoer-Dorp (Nm) 11 bus A, 2920 Kalmthout

Names & denominations

APOTHEEK NIEUWMOER

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

25 May 2000

Peppol

Active · Active since 20 Nov 2025

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK NIEUWMOER

Warning lights

Financials

What happened to APOTHEEK NIEUWMOER?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions